[Can cannabis use increase the risk for schizophrenic psychoses?].

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Fortschritte der Neurologie Psychiatrie

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1055/s-0032-1325415PMID 23139065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.

  2012cited by this paper
• Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings

  2011cited by this paper
• Cannabis, COMT and psychotic experiences

  2011cited by this paper
• The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.

  2011cited by this paper
• Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism

  2011cited by this paper
• Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain.

  2011cited by this paper
• Cannabis use in young people: the risk for schizophrenia.

  2011cited by this paper
• Cannabis with high cannabidiol content is associated with fewer psychotic experiences.

  2011cited by this paper
• AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder

  2011cited by this paper
• Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study

  2011cited by this paper
• Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

  2011cited by this paper
• Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines.

  2010cited by this paper
• Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

  2010cited by this paper
• Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

  2010cited by this paper
• Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use

  2010cited by this paper
• Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

  2010cited by this paper
• White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study.

  2010cited by this paper
• Structural MRI Findings in Long-Term Cannabis Users: What Do We Know?

  2010cited by this paper
• Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists

  2010cited by this paper
• Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies.

  2010cited by this paper
• Cannabis and psychosis/schizophrenia: human studies

  2009cited by this paper
• COMT Val158Met moderation of cannabis‐induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life

  2009cited by this paper
• Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.

  2009cited by this paper
• Neuroimaging in cannabis use: a systematic review of the literature

  2009cited by this paper
• Effects of cannabis use on outcomes of psychotic disorders: systematic review

  2008cited by this paper
• Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

  2008cited by this paper
• Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use

  2007cited by this paper
• Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

  2007cited by this paper
• Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.

  2007cited by this paper
• Changing incidence of psychotic disorders among the young in Zurich.

  2007cited by this paper
• Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

  2007cited by this paper
• The Neuropsychology of Cannabis and other Substance use in Schizophrenia: Review of the Literature and Critical Evaluation of Methodological Issues

  2007cited by this paper
• Substance dependence and non-dependence in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD): can an identical conceptualization be achieved?

  2006cited by this paper
• Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.

  2006cited by this paper
• The acute effects of cannabinoids on memory in humans: a review

  2006cited by this paper
• Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).

  2006cited by this paper
• Cannabidiol monotherapy for treatment-resistant schizophrenia

  2006cited by this paper
• Self-reported psychotic symptoms in the general population

  2006cited by this paper
• Does cannabis use cause schizophrenia?

  2006cited by this paper
• An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

  2006cited by this paper
• Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999

  2006cited by this paper
• Comorbid substance-use in schizophrenia: relation to positive and negative symptoms.

  2006cited by this paper
• [Doble diagnosis--psychosis and addiction].

  2006cited by this paper
• Cannabis use and outcome of recent onset psychosis

  2005cited by this paper
• Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.

  2005cited by this paper
• Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

  2005cited by this paper
• Tests of causal linkages between cannabis use and psychotic symptoms.

  2005cited by this paper
• Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies.

  2004cited by this paper
• The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

  2004cited by this paper
• Cannabis and risk of psychosis.

  2004cited by this paper
• The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes

  2004cited by this paper
• Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.

  2004cited by this paper
• Causal association between cannabis and psychosis: examination of the evidence

  2004cited by this paper
• Cannabis and the brain.

  2003cited by this paper
• Testing hypotheses about the relationship between cannabis use and psychosis.

  2003cited by this paper
• Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

  2002cited by this paper
• Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

  2002cited by this paper
• Cannabis use and psychosis: a longitudinal population-based study.

  2002cited by this paper
• A neurobiological basis for substance abuse comorbidity in schizophrenia.

  2001cited by this paper
• Psychiatric effects of cannabis

  2001cited by this paper
• Pharmacology and effects of cannabis: A brief review

  2001cited by this paper
• Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

  2001cited by this paper
• Elevated endogenous cannabinoids in schizophrenia.

  1999cited by this paper
• Substance abuse and the onset of schizophrenia.

  1996cited by this paper
• Cannabis Consumption as a Prognostic Factor in Schizophrenia

  1994cited by this paper
• The diagnosis and assessment of depression, mania, and psychosis by self-report.

  1993cited by this paper
• Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences.

  1990cited by this paper
• Impact of substance abuse on the course and outcome of schizophrenia.

  1990cited by this paper
• Cannabis and schizophrenia. A longitudinal study of Swedish conscripts.

  1987cited by this paper
• Marijuana: an overview.

  1987cited by this paper
• Marijuana use in schizophrenia: a clear hazard.

  1978cited by this paper
• The Environment and Disease: Association or Causation?

  1965cited by this paper

• Aufstieg und Fall des Jordan Belfort

  2019cites this paper
• Le médecin généraliste et la consommation de cannabis des adolescents en France.

  2016influential citation
• MDMA, cannabis, and cocaine produce acute dissociative symptoms.

  2015cites this paper
• Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness

  2014cites this paper
• Emerging drugs for schizophrenia: an update

  2014cites this paper
• Attitudes of family physicians towards adolescent cannabis users: a qualitative study in France.

  2014cites this paper
• Gambling problems in young people: experience from the Asian region

  2013cites this paper
• Fragmented Sleep, Fragmented Mind

  2012cites this paper